Published by Global Banking & Finance Review®
Posted on December 17, 2024
2 min readLast updated: January 27, 2026
Add as preferred source on Google
European shares hit two-week lows, led by declines in oil and healthcare stocks, as investors await central bank decisions. Airbus shares rose, while Bunzl's profit is impacted by deflation.
(Reuters) - European shares fell to two-week lows on Tuesday, led by energy and healthcare stocks, as investors awaited a slew of major central bank decisions later in the week.
The pan-European STOXX 600 index slipped 0.5% by 0815 GMT, trading at its lowest since Dec. 2.
Oil & gas stocks dropped 1.3% as crude prices nudged lower after China's economic data renewed demand concerns. [O/R]
Pharma stocks fell 1.2%.
The Federal Reserve's monetary policy decision on Wednesday is widely expected to result in a 25-bps rate reduction, but focus will on the pace of easing next year as the U.S. economy appears to be on a steady footing. The Bank of Japan and the Bank of England's rate announcements are due on Thursday.
Investors will also focus on German Ifo business climate index and ZEW economic sentiment numbers for December later on Tuesday.
Shares of Airbus climbed 1.6% after Deutsche Bank upgraded the stock to "buy" from "hold".
Britain's Bunzl fell 5% after the business supplies distributor said stickier-than-anticipated deflation will have a slight impact on its annual profit, especially in its Continental Europe division.
(Reporting by Sruthi Shankar in Bengaluru; Editing by Sherry Jacob-Phillips)
The main topic is the decline of European shares led by oil and healthcare stocks, amid anticipation of central bank decisions.
Oil stocks declined due to a drop in crude prices following China's economic data, which renewed demand concerns.
Airbus shares rose after a Deutsche Bank upgrade, while Bunzl's shares fell due to profit impacts from deflation.
Explore more articles in the Finance category
